| Literature DB >> 35336157 |
Claudia Carolina Carbonari1, Elizabeth Sandra Miliwebsky1, Gisela Zolezzi1, Natalia Lorena Deza1, Nahuel Fittipaldi2, Eduardo Manfredi1, Ariela Baschkier1, Beatriz Alejandra D'Astek1, Roberto Gustavo Melano3,4, Carla Schesi1, Marta Rivas1, Isabel Chinen1.
Abstract
Shiga toxin-producing Escherichia coli (STEC) is known as a pathogen associated with food-borne diseases. The STEC O145 serogroup has been related with acute watery diarrhea, bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Argentina has the highest rate of HUS worldwide with 70% of the cases associated with STEC infections. We aimed to describe the epidemiology and genetic diversity of STEC O145 strains isolated across Argentina between 1998-2020. The strains isolated from 543 cases of human disease and four cattle, were pheno-genotipically characterized. Sequencing of five strains was performed. The strains were serotyped as O145:NM[H28]/H28, O145:H25, and O145:HNT, and mainly characterized as O145:NM[H28]/stx2a/eae/ehxA (98.1%). The results obtained by sequencing were consistent with those obtained by traditional methods and additional genes involved in different mechanisms of the pathogen were observed. In this study, we confirmed that STEC O145 strains are the second serogroup after O157 and represent 20.3% of HUS cases in Argentina. The frequency of STEC O145 and other significant serogroups is of utmost importance for public health in the country. This study encourages the improvement of the surveillance system to prevent severe cases of human disease.Entities:
Keywords: STEC O145; epidemiology; genetic diversity; hemolytic uremic syndrome; surveillance
Year: 2022 PMID: 35336157 PMCID: PMC8950694 DOI: 10.3390/microorganisms10030582
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Distribution of Shiga toxin-producing Escherichia coli (STEC) O145 infections occurred in Argentina over time.
Figure 2Clinical presentation of STEC O145 infections throughout the years.
Resistance profiles associated to the different clinical presentations.
| # | Resistance Profile * | Origin | No Strains |
|---|---|---|---|
| 1 | AMP | 3HUS/2BD | 5 |
| 2 | AMP/CHL/S/TE | HUS | 1 |
| 3 | AMP/S | HUS | 2 |
| 4 | AMP/S/TE | HUS/unknown | 2 |
| 5 | AMP/S/TE/TMS | HUS | 5 |
| 6 | AMP/S/TMS | 3HUS/2BD | 7 |
| 7 | AMP/TE/TMS | fatal HUS | 1 |
| 8 | A/TMS | HUS/D | 2 |
| 9 | CHL/S/TE/TMS | HUS | 1 |
| 10 | CHL/TE/TMS | 2HUS/D | 3 |
| 11 | G/S/TE | HUS | 1 |
| 12 | NA/T | HUS/BD | 2 |
| 13 | S/TE | HUS/BD | 3 |
| 14 | S/TE/TMS | unknown | 1 |
| 15 | S | HUS | 1 |
| 16 | TE | 5HUS/BD/4D | 10 |
| 17 | TE/TMS | HUS/BD/D | 3 |
* Ampicillin (AMP), chloramphenicol (CHL), gentamicin (GE), nalidixic acid (NA), streptomycin (ST), tetracycline (TE) and trimethoprim-sulfamethoxazole (TMS). Hemolytic Uremic Syndrome (HUS), bloody diarrhea (BD) and diarrhea (D).
Figure 3Clonal relatedness of different STEC O145 strains by XbaI-PFGE. City of Buenos Aires (CABA).
Figure 4Clonal relatedness of different STEC O145 including one cluster with human and bovine origin strains, by XbaI-PFGE.
Accession numbers and assembly metrics of the annotated STEC O145:NM[H28].
| Isolate No. | Origin | Place-Province/ | NCBI Accession No. | No. of Scaffolds | Genome Size (bp) |
| G+C Content (%) |
|---|---|---|---|---|---|---|---|
| GN1228 |
| Santa Fe/2002 | JAJBBW000000000 | 123 | 5,239,290 | 173,877 | 50 |
| GN1229 |
| City of Buenos Aires/2006 | JAJBBV000000000 | 144 | 5,345,892 | 158,581 | 50 |
| GN1230 |
| Buenos Aires/2007 | JAJBBU000000000 | 156 | 5,251,985 | 160,369 | 50 |
| GN1231 |
| Neuquén/2007 | JAJBBT000000000 | 127 | 5,376,704 | 152,017 | 50 |
| GN1232 |
| Rio Negro/2008 | JAJBBS000000000 | 142 | 5,259,376 | 201,633 | 50 |
Distribution of virulence and resistance genes in STEC O145 strains.
| Virulence Genes | Product | STEC O145 Strains | ||||
|---|---|---|---|---|---|---|
| Shiga Toxins | ||||||
|
| Shiga toxin 1 subtype a | 1 | ||||
|
| Shiga toxin 2 subtype a | 1 | 1 | 1 | 1 | |
| Adhesins | ||||||
|
| Intimin | 1 | 1 | 1 | 1 | 1 |
|
| IrgA homologue adhesin | 1 | 1 | 1 | 1 | 1 |
| LEE encoded Type III secretory system proteins | ||||||
|
| Translocated intimin receptor | 1 | 1 | 1 | 1 | |
|
| EPEC secreted protein A | 1 | 1 | 1 | 1 | 1 |
|
| EPEC secreted protein B | 1 | 1 | 1 | 1 | 1 |
| Non-LEE encoded effector proteins | ||||||
|
| Non-LEE encoded effector protein A | 1 | 1 | 1 | 1 | 1 |
|
| Non-LEE encoded effector protein B | 1 | 1 | 1 | 1 | 1 |
|
| Non-LEE encoded effector protein C | 1 | 1 | 1 | 1 | |
| Phage encoded type III secretory system proteins | ||||||
|
| 1 | 1 | 1 | 1 | 1 | |
|
| 1 | 1 | 1 | 1 | 1 | |
|
| Cell-cycle inhibiting factor | 1 | 1 | 1 | 1 | 1 |
| Plasmid encoded virulence factors | ||||||
|
| Enterohemolysin | 1 | 1 | 1 | 1 | |
|
| Catalase peroxidase | 1 | 1 | 1 | 1 | |
|
| Extracellular serine protease | 1 | 1 | 1 | 1 | |
|
| Enterobactin siderophore receptor protein | 1 | ||||
|
| Aerobactin synthetase | 1 | 1 | 1 | 1 | 1 |
|
| Ferric aerobactin receptor | 1 | 1 | 1 | 1 | 1 |
|
| Colicin M | 1 | ||||
|
| Colicin V (Microcin) | 1 | ||||
| Antimicrobial resistance genes | ||||||
|
| Multidrug transporter | 1 | 1 | 1 | 1 | 1 |
|
| Aminoglycoside resistance | 1 | ||||
|
| Trimethoprim resistance | 1 | ||||
|
| Colistin resistance | 1 | 1 | |||
|
| Tetracycline resistance | 1 | ||||
|
| Sulphonamide resistance | 1 | ||||
|
| Sulphonamide resistance | 1 | ||||
|
| Beta-lactam resistance | 1 | ||||
| Others | ||||||
|
| Increased serum survival | 1 | 1 | 1 | 1 | 1 |
|
| EAST-1 heat-stable toxin | 1 | 1 | 1 | 1 | 1 |
|
| Tellurium ion resistance protein | 1 | 1 | 1 | 1 | 1 |
|
| Toxin B | 1 | 1 | 1 | ||
|
| Outer membrane hemin receptor | 1 | 1 | 1 | 1 | 1 |
|
| Outer membrane protease | 1 | 1 | 1 | 1 | 1 |
|
| Outer membrane protein complement resistance | 1 | 1 | 1 | 1 | 1 |
|
| ABC transporter protein MchF | 1 | ||||
|
| Polysialic acid capsule biosynthesis protein | 1 | 1 | 1 | 1 | 1 |
|
| Iron transport protein | 1 | ||||
|
| Hemolysin F | 1 | ||||
Phage sequences classified according to the PHASTER scores as intact, questionable, and incomplete >90, 70–90, <70, respectively.
| Prophages | Type of Sequences | STEC O145 Strains | ||||||
|---|---|---|---|---|---|---|---|---|
| Intact | Incomplete | Questionable | 1228 | 1229 | 1230 | 1231 | 1232 | |
| Entero_YYZ_2008_NC_011356 | x | x |
| |||||
| Stx2_c_1717_NC_011357 | x | x | ||||||
| Entero_DE3_NC_042057 | x | x |
|
|
| |||
| Yersin_L_413C_NC_004745 | x | x |
|
|
| |||
| Vibrio_12B8_NC_021073 |
|
| ||||||
| Entero_phi92_NC_023693 |
|
|
| |||||
| Entero_VT2phi_272_NC_028656 |
|
|
| |||||
| Entero_mEp460_NC_019716 |
|
|
| |||||
| Escher_P13374_NC_018846 |
|
| ||||||
| Entero_JSE_NC_012740 |
|
| ||||||
| Entero_WPhi_NC_005056 |
|
| ||||||
| Entero_P2_NC_001895 |
|
| ||||||
The result of each strain is represented by a different color.